India Pharma Outlook Team | Monday, 11 August 2025
Meril, a global leader in advanced medical solutions, brought together some of India’s most distinguished oncology experts at OncoXchange, a high-impact panel discussion held at Meril Academy, Aloft Hotel, Aerocity, New Delhi. The event catalysed progressive dialogue around the future of cancer care in India.
The event witnessed the presence of 26 elite surgical consultants and directors from the medical community across from the Indian oncology community, representing a wide spectrum of expertise and experience. Leading the discussion on the multidisciplinary approach to cancer treatment were esteemed panelists Dr. Naveen Sanchety, Dr. Vedant Kabra, Dr. Azhar Perwaiz, and Dr. Ashish Goel, with moderation by Dr. Harit Chaturvedi and Dr. Pradeep Jain.
Dr. Harit Chaturvedi remarked, “At OncoXchange, we share best practices in oncology and explore ways to drive meaningful transformation. We focus on fostering a cultural shift toward a multidisciplinary approach and addressing how we can effectively overcome challenges and resolve conflicts to deliver better patient care. The future of oncology in India lies in integrating AI seamlessly into clinical workflows ensuring the highest quality of patient data, prioritising ethical practices, equipping healthcare professionals with digital skills and keeping patient-centricity at the core. Our vision for Indian oncology embraces a multidisciplinary approach to cancer treatment, fostering innovation beyond surgery, and recognising the expanding role of Indian MNCs. By addressing gaps in treatment options and leveraging newer technologies for precise treatment planning, we aim to put Indian oncology firmly on the world map.”
In another insightful discussion centered on innovation beyond surgery and the expanding role of Indian MNCs, key perspectives were shared by Dr. Asit Arora, Dr. Rudra Prasad Acharya, Dr. Saleem Naik, and Nitin Thakur. This session was steered by moderators Dr. (Prof.) Chintamani and Dr. Geeta Kadayaprath.
Also Read: Role of Optical Imaging in Early Cancer Detection and Treatment
“Innovation in cancer care is no longer confined to the operating room — it extends to technology, training, and the global leadership Indian MNCs are beginning to shape. The future lies in thinking beyond surgery to create a holistic ecosystem of solutions,” said Dr. (Prof.) Chintamani.
The forum was further enriched by valuable perspectives on "Putting Indian Oncology on the World Map" from Dr. Saumitra Rawat, Dr. Mudit Agarwal, Dr. Nikhil Agrawal, Dr. Arvind Kumar, and Dr. (Prof.) S.V.S. Deo made OncoXchange a truly collaborative and insightful gathering.
Commenting on Indian oncology, Dr. (Prof.) S.V.S. Deo said, “Indian oncology has the expertise, innovation, and collaborative spirit to make a global impact. Platforms like OncoXchange are vital in uniting our brightest minds to put India firmly on the world map of cancer care. Our aim is to transformation patient care and bring change in the Indian oncology ecosystem.” “Cancer cases are rising in India, from GI to thoracic, and we at Meril remain committed to transforming care through innovation, training, and collaboration. OncoXchange is more than a discussion by bringing together the sharpest minds in cancer care. We aim to foster a shared vision for innovation, collaboration, and patient-centric treatment strategies,” said Mr. Nitin Thakur, Business Head – Sales and Marketing, Meril Lifesciences
Vivek Shah, CEO, Meril Lifesciences, said, “Our flagship platform, OncoXchange, is designed to transform cancer treatment by bringing together the brightest minds to co-create patient-centric, integrated solutions for the future of oncology care. Through Meril Academy, we empower onco-surgeons with advanced minimally invasive techniques, and our flagship event helps bring together the brightest minds to shape a future driven by patient-centric solutions and integrated surgical support.”
By spotlighting key issues such as AI integration, cross-disciplinary treatment planning, and the untapped potential of Indian innovation, OncoXchange reaffirmed Meril’s commitment to transforming the future of cancer care both in India and globally.
